Lloyd Mitchell Segal, President and CEO at Repare Therapeutics Inc. (RPTX), sold 77,000 shares at $30.64 ($2.4M) on 2021-06-04, disclosed to the SEC on 2021-06-07.
Open-market sale of $2.4M RPTX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.74 | 6,648 | $211K | 8.8% |
| 2 | $31.74 | 6,648 | $211K | 8.8% |
| 3 | $30.64 | 17,180 | $526K | 22.0% |
| 4 | $30.64 | 17,180 | $526K | 22.0% |
| 5 | $31.25 | 5,000 | $156K | 6.5% |
| 6 | $31.36 | 12,172 |
| $382K |
| 15.9% |
| 7 | $31.36 | 12,172 | $382K | 15.9% |
| Total | $31.10 avg | 77,000 | $2.4M | 100% |
| Filing → |
| RPTX | SELL | 2024-03-27 | $37K | — | Filing → |
| RPTX | SELL | 2021-06-30 | $110K | — | Filing → |
| RPTX | SELL | 2021-06-10 | $55K | — | Filing → |